Israel Has Been Working on Plague Vaccine Since 2025
Researchers in Israel are developing an experimental mRNA vaccine against pneumonic plague, as concerns about potential outbreaks continue to draw … Read More The post Israel Has Been Working on Plague Vaccine Since 2025 appeared first on ProPakistani .
Researchers in Israel are developing an experimental mRNA vaccine against pneumonic plague, amid growing concerns over potential outbreaks of the disease. The vaccine is being worked on by researchers from Tel Aviv University and the Israel Institute for Biological Research, under the leadership of Prof. Dan Peer. So far, the vaccine has been tested in mice.
The experimental vaccine utilizes mRNA technology to specifically target pneumonic plague, which is a severe form of plague caused by the bacterium Yersinia pestis. Presently, the project remains in the experimental stage and has not yet received approval for human use. Israel is reportedly the sole country currently engaged in the development of an mRNA vaccine specifically designed to combat pneumonic plague, although there is no definitive confirmation that other research teams around the world are not pursuing similar initiatives.
For now, the Israeli project serves as an early-stage endeavor aiming to ascertain whether mRNA technology can offer protection against pneumonic plague. The announcement about Israel's plague vaccine project was initially reported by ProPakistani.
Written by urgent.news from ProPakistani's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
